First such study in the world aims to find out if Sativex combined with chemotherapy can help treat glioblastoma.

Cancer charities and the NHS are preparing to investigate whether a cannabis-based mouth spray can treat brain tumours and help patients to live longer.

Doctors will give patients across the UK with a recurrent brain tumour called a glioblastoma the drug, which is known as Sativex, alongside a chemotherapy medication – temozolomide – in a clinical trial in an attempt to kill off cancerous cells.

It will be the first such study in the world.

– Read the entire article at The Guardian.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

 

Bud Digest